All about Brintellix, the new FDA-approved antidepressant

web-WELL_Antidepres_1009

Nearly 15 million Americans suffer from major depressive disorder, the leading cause of disability for adults between 18 and 44 years old, according to the National Institute of Mental Health. Worldwide, fewer than half get the treatment they need.

But a new kid on the serotonin block offers hope for an effective treatment: Last week, the Food and Drug Administration (FDA) approved Brintellix (vortioxetine), a serotonin reuptake inhibitor, for the treatment of major depression.

Major depressive disorder is characterized by symptoms – such as low mood, loss of interest, fatigue, insomnia, difficulty concentrating and changes in appetite – that persist every day for at least two weeks, says Dr. Michael Thase, professor of psychiatry at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia and one of the consultants who advised on the study of Brintellix by developers Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck).

SSRIs lessen depression by altering naturally occurring chemical messengers called neurotransmitters, which are used to communicate between brain cells.

“It’s a complex process,” Thase explains. “It’s like putting a key into a lock: Once reuptake of serotonin is inhibited and more neurotransmitter is available in the synapse [an area that permits neurons to pass signals to other cells], changes happen in inside the neurons and in genes that affect the stress response, which in turn can improve mood and other related symptoms.”

All antidepressants have that potential, but what’s different about Brintellix, Thase says, is that it has three other effects on other aspects of serotonin transmission, which might broaden its profile of response or lessen certain side effects – such as fewer sexual side effects — than currently available medications.

One study showed Brintellix might also help improve cognitive symptoms of depression, such as concentration, Thase says. But more studies are needed before the FDA will allow the company to advertise these potential secondary benefits.

Because major depression is so multifaceted, it’s helpful for doctors to have a variety of options for treatment, Thase says.

“Although Brintellix primarily affects serotonin, like other widely used antidepressants, its particular profile is different than anything else we have,” he says. “But what you can’t tell yet on the basis of the double blind studies is if these differences will be really important for our patients or if they’ll be trivial in terms of extra benefits. It’ll take some time to ascertain the extent these differences could make for patients.”


News
Entertainment
Sports
Lifestyle
News

Mets mascot Mr. Met target of Bill Clinton…

Mets mascot Mr. Met has told how he ended up in the crosshairs of a Secret Service sniper rifle. The man behind the Mr. Met…

Local

Oval oasis: Summer of fun kicks off this…

A bold partnership between the Fairmount Park Conservancy and the city's Parks and Recreation Department is kicking off this weekend with family activities re-activating this unused public space.

Local

African couple claiming misidentification in robbery case to…

At a bail hearing today for Vickson and Lorfu Korlewala, charged in the robbery of an 80-year-old woman, bail was reduced from $1 million total to $500,000.

International

Jews in eastern Ukraine ordered to register, Kerry…

Secretary of State John Kerry condemned reports that Jews in eastern Ukraine had been ordered to register with the authorities "or suffer the consequences."

Movies

Review: 'Transcendence' is not stupid but sometimes lacks…

The cyberthriller "Transcendence" explores artificial intelligence, nanotechnology and other ethical quandaries, but has too much ambition, if anything.

Television

Dick Wolf to bring fictionalized world of 'Law…

A&E has ordered a pilot called "D.O.A." from "Law and Order" mastermind Dick Wolf that will focus on real detectives reexamining cold cases. A trio…

Television

Shane West talks WGN America's 'Salem'

The actor on history lessons, a new network and showing his butt.

Music

Both feet on the ground with Aimee Mann…

What began with a cool double-bill of Ted Leo opening for Aimee Mann morphed into a full-fledged collaborative project that they're calling The Both. “There…

NHL

Rangers draw first blood against Flyers in Game…

Brad Richards and Derek Stepan scored power-play goals 47 seconds apart to lead the Rangers to a 4-1 win.

MLB

Jimmy Rollins is key to Phillies success

When John Kruk was asked about what the Phillies need to contend for a playoff berth, the ESPN analyst said Jimmy Rollins needs to play like a MVP again.

MLB

Ben Revere lifts Phillies to avoid sweep

Ben Revere came through with a two-out RBI single against Atlanta’s tough lefthander Alex Wood.

NBA

Season wrap: 76ers make the grade

The 76ers opened the 2013-14 season with a victory over the Miami Heat. The Sixers closed the season with a win at Miami.

Style

Light-up nail art syncs with phone

This Japanese technology syncs light-up nail art with your phone.

Wellbeing

Why is dance cardio taking off in NYC?

Instructors at some of the city's hottest classes explain why.

Travel

Earth Day travel in the Florida Keys

See why this eco-friendly destination deserves your attention.

Tech

Sorry, Facebook — FarmVille goes mobile with 'Country…

Zynga has released a version of the hit "FarmVille" tailored for smartphones and tablets in the hope of reaping a bumper crop of players.